Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 6, 2007Antimicrobial Agents and ChemotherapyOpen Access

Pseudomonas aeruginosa May Accumulate Drug Resistance Mechanisms without Losing Its Ability To Cause Bloodstream Infections

View Full Paper
Ask AI
Bookmark
Share

Authors

DHDidier HocquetPBP. BerthelotMRMicheline Roussel‐Delvallez

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hocquet et al. (2007) studied this question.

synapsesocial.com/papers/6a898103b1e5d05ea8ec742fhttps://doi.org/10.1128/aac.00503-07
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Resistance to β-Lactam Antibiotics in <i>Pseudomonas aeruginosa</i> Due to Interplay between the MexAB-OprM Efflux Pump and β-Lactamase1999 · 80 citations
  2. 2Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy2003 · 240 citations
  3. 3Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas aeruginosa2006 · 748 citations
  4. 4MexXY-OprM Efflux Pump Is Necessary for Adaptive Resistance of <i>Pseudomonas aeruginosa</i> to Aminoglycosides2003 · 178 citations
  5. 5MexAB-OprM- and MexXY-Overproducing Mutants Are Very Prevalent among Clinical Strains of <i>Pseudomonas aeruginosa</i> with Reduced Susceptibility to Ticarcillin2007 · 52 citations